BR0209020A - Composição farmacêutica de polialilamina - Google Patents
Composição farmacêutica de polialilaminaInfo
- Publication number
- BR0209020A BR0209020A BR0209020-1A BR0209020A BR0209020A BR 0209020 A BR0209020 A BR 0209020A BR 0209020 A BR0209020 A BR 0209020A BR 0209020 A BR0209020 A BR 0209020A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- polyallylamine
- polymer
- diluent
- disclosed
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920000083 poly(allylamine) Polymers 0.000 title 1
- 229920000642 polymer Polymers 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA DE POLIALILAMINA". é descrita uma composição farmacêutica compreendendo um polímero de hidrocloreto de polialilamina estável na qual entre aproximadamente 4% a aproximadamente 12% por peso do polímero é um ânion cloreto e um transportador farmaceuticamente aceitável ou um diluente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28444501P | 2001-04-18 | 2001-04-18 | |
| PCT/US2002/011408 WO2002085378A1 (en) | 2001-04-18 | 2002-04-10 | Low salt forms of polyallylamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0209020A true BR0209020A (pt) | 2004-08-10 |
Family
ID=23090248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0209020-1A BR0209020A (pt) | 2001-04-18 | 2002-04-10 | Composição farmacêutica de polialilamina |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7541024B2 (pt) |
| EP (1) | EP1379258B1 (pt) |
| JP (2) | JP5170932B2 (pt) |
| KR (1) | KR20040018357A (pt) |
| CN (1) | CN1290515C (pt) |
| AT (1) | ATE331525T1 (pt) |
| AU (1) | AU2002252632B2 (pt) |
| BR (1) | BR0209020A (pt) |
| CA (1) | CA2444587C (pt) |
| DE (1) | DE60212819T2 (pt) |
| ES (1) | ES2268013T3 (pt) |
| MX (1) | MXPA03009572A (pt) |
| NZ (1) | NZ528829A (pt) |
| WO (1) | WO2002085378A1 (pt) |
| ZA (2) | ZA200308065B (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| US7220406B2 (en) * | 2002-10-22 | 2007-05-22 | Genzyme Corporation | Method for promoting bone formation |
| WO2005032563A1 (en) * | 2003-09-02 | 2005-04-14 | Genzyme Corporation | Method for reducing vascular inflammation |
| KR101223335B1 (ko) | 2004-03-30 | 2013-01-17 | 리립사, 인크. | 이온 결합 조성물 |
| US7985418B2 (en) * | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| EP1951266A2 (en) | 2005-09-02 | 2008-08-06 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
| CN101272762B (zh) | 2005-09-15 | 2013-02-06 | 基酶有限公司 | 胺聚合物的小袋制剂 |
| JP2009542653A (ja) * | 2006-07-05 | 2009-12-03 | ジェンザイム コーポレーション | リン酸塩過剰血症のための鉄(ii)含有治療剤 |
| JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
| US8163799B2 (en) | 2006-12-14 | 2012-04-24 | Genzyme Corporation | Amido-amine polymer compositions |
| EP2016947A1 (en) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
| WO2009125433A2 (en) * | 2008-04-08 | 2009-10-15 | Usv Limited | Process for preparation of amine polymer salt |
| US8404784B2 (en) * | 2008-12-03 | 2013-03-26 | Navinta Llc | Manufacturing process of making polymeric amine salts |
| CA2765370A1 (en) * | 2009-06-16 | 2010-12-23 | Watson Pharma Private Limited | Processes for the preparation of sevelamer carbonate |
| US9181364B2 (en) * | 2010-02-24 | 2015-11-10 | Relypsa, Inc. | Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants |
| DK3287133T3 (da) | 2013-06-05 | 2019-07-01 | Tricida Inc | Proton-bindende polymerer til oral indgivelse |
| KR102625115B1 (ko) * | 2014-12-10 | 2024-01-12 | 트리시다, 인크. | 경구 투여용 양성자-결합 폴리머 |
| KR102655774B1 (ko) | 2016-05-06 | 2024-04-05 | 트리시다, 인크. | 산-염기 장애의 치료를 위한 조성물 및 방법 |
| JP6792640B2 (ja) | 2016-12-28 | 2020-11-25 | 富士フイルム株式会社 | 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法 |
| CA3079171C (en) | 2017-10-16 | 2023-09-12 | Fujifilm Corporation | Therapeutic agent for hyperphosphatemia and particles |
| CN111225674A (zh) | 2017-10-16 | 2020-06-02 | 富士胶片株式会社 | 高磷血症治疗剂 |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| CN110753217B (zh) * | 2019-10-28 | 2022-03-01 | 黑芝麻智能科技(上海)有限公司 | 色彩平衡方法和装置、车载设备以及存储介质 |
| US11572355B2 (en) * | 2020-07-16 | 2023-02-07 | The Board Of Trustees Of The University Of Alabama | Methods for synthesizing vinylidenes and alkenes |
| CN112047854B (zh) * | 2020-10-20 | 2021-07-02 | 中国科学院长春应用化学研究所 | 一种n-乙烯基烷基酰胺的制备方法 |
| WO2023023938A1 (en) * | 2021-08-24 | 2023-03-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Polymers, compositions and methods for treating hyperuricemia |
| ES2980624T3 (es) * | 2021-08-24 | 2024-10-02 | Waterstone Pharmaceuticals Wuhan Co Ltd | Polímeros, composiciones y métodos para tratar hiperuricemia |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4222921A (en) * | 1978-06-19 | 1980-09-16 | Monsanto Company | Polyamine/epihalohydrin reaction products |
| JPS6090243A (ja) | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | 小球状モノアリルアミン橋かけ重合体の製造方法 |
| CA1220896A (en) | 1983-11-10 | 1987-04-21 | Susumu Harada | Process for producing polymers of monoallylamine |
| US4614593A (en) * | 1985-03-28 | 1986-09-30 | Ethyl Corporation | Demulsification of oil-in-water emulsions |
| IE914179A1 (en) * | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
| US5487888A (en) | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
| US5624963A (en) | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
| US5703188A (en) | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
| US5900475A (en) | 1994-06-10 | 1999-05-04 | Geltex Pharmaceuticals, Inc. | Hydrophobic sequestrant for cholesterol depletion |
| US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
| US5618530A (en) | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
| WO1996021454A1 (en) * | 1995-01-12 | 1996-07-18 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
| US5925379A (en) | 1997-03-27 | 1999-07-20 | Geltex Pharmaceuticals, Inc. | Interpenetrating polymer networks for sequestration of bile acids |
| JP2003183168A (ja) * | 1997-04-04 | 2003-07-03 | Chugai Pharmaceut Co Ltd | リン酸結合性ポリマー含有製剤 |
| TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
| US6423754B1 (en) * | 1997-06-18 | 2002-07-23 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with polyallylamine polymers |
| US5985938A (en) | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
| US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
| AU2682499A (en) | 1998-02-17 | 1999-08-30 | Dimitri R. Kioussis | Anion binding polymers and the use thereof |
| TW568788B (en) * | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
| US6180754B1 (en) * | 1999-09-03 | 2001-01-30 | The Dow Chemical Company | Process for producing cross-linked polyallylamine polymer |
| US6733780B1 (en) * | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
-
2002
- 2002-04-10 ES ES02721716T patent/ES2268013T3/es not_active Expired - Lifetime
- 2002-04-10 CA CA002444587A patent/CA2444587C/en not_active Expired - Fee Related
- 2002-04-10 AU AU2002252632A patent/AU2002252632B2/en not_active Ceased
- 2002-04-10 MX MXPA03009572A patent/MXPA03009572A/es active IP Right Grant
- 2002-04-10 EP EP02721716A patent/EP1379258B1/en not_active Expired - Lifetime
- 2002-04-10 BR BR0209020-1A patent/BR0209020A/pt not_active IP Right Cessation
- 2002-04-10 JP JP2002582951A patent/JP5170932B2/ja not_active Expired - Fee Related
- 2002-04-10 CN CNB02808487XA patent/CN1290515C/zh not_active Expired - Fee Related
- 2002-04-10 WO PCT/US2002/011408 patent/WO2002085378A1/en not_active Ceased
- 2002-04-10 AT AT02721716T patent/ATE331525T1/de active
- 2002-04-10 DE DE60212819T patent/DE60212819T2/de not_active Expired - Lifetime
- 2002-04-10 NZ NZ528829A patent/NZ528829A/en unknown
- 2002-04-10 KR KR10-2003-7013677A patent/KR20040018357A/ko not_active Ceased
- 2002-04-17 US US10/125,684 patent/US7541024B2/en not_active Expired - Fee Related
-
2003
- 2003-10-16 ZA ZA200308065A patent/ZA200308065B/en unknown
- 2003-10-16 ZA ZA200308063A patent/ZA200308063B/en unknown
-
2009
- 2009-04-21 US US12/427,127 patent/US8377428B2/en not_active Expired - Fee Related
-
2010
- 2010-02-01 JP JP2010020592A patent/JP5243466B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US8377428B2 (en) | 2013-02-19 |
| CN1290515C (zh) | 2006-12-20 |
| JP5170932B2 (ja) | 2013-03-27 |
| ZA200308065B (en) | 2004-09-14 |
| EP1379258A1 (en) | 2004-01-14 |
| JP2010111704A (ja) | 2010-05-20 |
| ES2268013T3 (es) | 2007-03-16 |
| CA2444587A1 (en) | 2002-10-31 |
| DE60212819D1 (de) | 2006-08-10 |
| CA2444587C (en) | 2008-10-21 |
| DE60212819T2 (de) | 2006-11-23 |
| JP5243466B2 (ja) | 2013-07-24 |
| JP2004526777A (ja) | 2004-09-02 |
| US20020159968A1 (en) | 2002-10-31 |
| US20100068167A1 (en) | 2010-03-18 |
| AU2002252632B2 (en) | 2004-09-23 |
| US7541024B2 (en) | 2009-06-02 |
| MXPA03009572A (es) | 2004-02-12 |
| WO2002085378A1 (en) | 2002-10-31 |
| HK1058620A1 (en) | 2004-05-28 |
| ATE331525T1 (de) | 2006-07-15 |
| CN1503676A (zh) | 2004-06-09 |
| ZA200308063B (en) | 2005-01-17 |
| NZ528829A (en) | 2006-06-30 |
| EP1379258B1 (en) | 2006-06-28 |
| KR20040018357A (ko) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0209020A (pt) | Composição farmacêutica de polialilamina | |
| SE0300010D0 (sv) | Novel Compounds | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| LU92853I2 (fr) | Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et l'emtricitabine | |
| HK1039108A1 (zh) | 以n-氰甲基酰胺作为蛋白酶抑制剂 | |
| DE602004024375D1 (de) | Carboxamidderivate | |
| LU92315I2 (fr) | Combinaison comprenant aliskiren, ou un de ses sels pharmaceutiquement acceptable, et amlodipine, ouun de ses sels pharmaceutiquement acceptable | |
| PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
| MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
| MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| SE9802208D0 (sv) | Novel compounds | |
| SE0102440D0 (sv) | New compound | |
| SE0102055D0 (sv) | New Compounds | |
| WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
| MXPA04001419A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson. | |
| SE9802209D0 (sv) | Novel compounds | |
| SE0001916D0 (sv) | Novel formulation | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| TW200510370A (en) | Urea derivatives | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: GENZYME CORPORATION (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080029522/SP DE 14/05/2008. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |